Crefmirlimab Human Monoclonal Antibody
Crefmirlimabis a research-grade recombinant antibody targeting CD8. Produced in mammalian cells with native-like glycosylation. Highlights Research Grade: For PK/PD studies, assay development, and ADA research. Native Glycosylation: Mammalian expression ensures native-like patterns.
Product Specifications
Product Name Alternative
T-cell surface glycoprotein CD8 alpha chain, CD8a, T-lymphocyte differentiation antigen T8/Leu-2, MAL, CD8A
UniProt
P01732
Reactivity
Human
Clonality
Monoclonal
Conjugation
Unconjugated
Purification
Purified by Ion Exchange Chromatography.
Concentration
Lot dependent
Purity
>95% purity as determined by SDS-PAGE.
Form
Liquid
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Tested Applications
ELISA, FA, FACS, In vivo
Host or Source
Human Humanized
Preservative
0.01M PBS, pH 7.4.
Isotype
(scFv-kappa-heavy) -h- CH3
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Mammaglobin (SCGB2A2) (Breast Cancer Marker) (MGB1/2000), CF647 conjugate, 0.1mg/mL
Texas Red Conjugated Rabbit Polyclonal Antibody to Mouse IgG
CytoLinerTM 410/450 Fixed Cell Membrane Stain, 1000 labelings
PAI-RBP1 / SERBP1 / SERPINE1 (SERBP1/3497), 0.2mg/mL
